SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: georgiabiotech who wrote (10137)7/8/2007 2:21:43 PM
From: Icebrg  Read Replies (1) | Respond to of 10280
 
That was claimed recently by Southwell in a presentation, so I suppose it is correct. He seemed to think that it is positive for Sepracor as they will then be the only company actively promoting a sleep drug.

Erik



To: georgiabiotech who wrote (10137)7/9/2007 9:24:16 AM
From: Rocky9  Respond to of 10280
 
Southwell said that the generic date for Ambien CR would be Oct 2008.